Investor Relations | Corporate Information

April 21, 2025	Discovery that citrate, which keeps the body's internal environment weakly alkaline, is effective in preventing or treating peripheral neuropathy induced by anticancer drugs. (pdf, 445KB)
January 31, 2025	Summary of Consolidated Financial Results for the Third Quarter of FY2024. (pdf, 209KB)
January 31, 2025	Third quarter business summary FY2024. (pdf, 423KB)
October 31, 2024	Summary of Consolidated Financial Results for the Second Quarter of FY2024. (pdf, 186KB)
October 31, 2024	Second quarter business summary FY2024. (pdf, 674KB)
August 30, 2024	Corporate Report 2024 (Annual Report FY2023) (pdf, 2.2MB)
July 31, 2024	Summary of Consolidated Financial Results for the First Quarter of FY2024. (pdf, 173KB)
July 31, 2024	First quarter business summary FY2024. (pdf, 433KB)
June 29, 2024	Notice of the 92nd Ordinary General Meeting of Shareholders. (PDF, 375KB)
May 13, 2024	Summary of Consolidated Financial Results for the Fiscal Year 2023. (pdf, 204KB)
May 13, 2024	Business Summary FY2023. (pdf, 566KB)
May 7, 2024	Revision of FY2023 Forecasts. (pdf, 134KB)
January 31, 2024	Summary of Consolidated Financial　Results for the Third Quarter of Fiscal Year 2023. (pdf, 152KB)
January 31, 2024	Third quarter business summary FY2023. (pdf, 918KB)
October 31, 2023	Summary of Consolidated Financial　Results for the Second Quarter of Fiscal Year 2023. (pdf, 157KB)

IR Calendar